For: | Kimura A, Ogata K, Altan B, Yokobori T, Mochiki E, Yanai M, Kogure N, Yanoma T, Suzuki M, Bai T, Kuwano H. Nuclear heat shock protein 110 expression is associated with poor prognosis and hyperthermo-chemotherapy resistance in gastric cancer patients with peritoneal metastasis. World J Gastroenterol 2017; 23(42): 7541-7550 [PMID: 29204054 DOI: 10.3748/wjg.v23.i42.7541] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i42/7541.htm |
Number | Citing Articles |
1 |
Abdullah Hoter, Hassan Y. Naim. Heat Shock Proteins and Ovarian Cancer: Important Roles and Therapeutic Opportunities. Cancers 2019; 11(9): 1389 doi: 10.3390/cancers11091389
|
2 |
Haitao Liu, Sha Zhang, Yi Liu, Jing Ma, Wei Chen, Tao Yin, Tongbin Li, Bin Liang, Ling Tao. Knockdown of HSP110 attenuates hypoxia-induced pulmonary hypertension in mice through suppression of YAP/TAZ-TEAD4 pathway. Respiratory Research 2022; 23(1) doi: 10.1186/s12931-022-02124-4
|
3 |
Ziying Lei, Xiaohong Xia, Qiaoling He, Jiali Luo, Yan Xiong, Jin Wang, Hongsheng Tang, Tianpei Guan, Yun Tian, Songhui Xu, Shuzhong Cui. HSP70 promotes tumor progression by stabilizing Skp2 expression in gastric cancer cells. Molecular Carcinogenesis 2021; 60(12): 826 doi: 10.1002/mc.23346
|
4 |
Congke Zhao, Honglin Xiang, Mengqi Li, Ruizhe Gao, Yifan Zhang, Qianbin Li, Liqing Hu. Heat shock protein 110: A novel candidate for disease diagnosis and targeted therapy. Drug Discovery Today 2024; 29(12): 104199 doi: 10.1016/j.drudis.2024.104199
|
5 |
Gustavo J. Gozzi, Daniel Gonzalez, Christophe Boudesco, Alexandre M. M. Dias, Guillaume Gotthard, Burhan Uyanik, Lucile Dondaine, Guillaume Marcion, François Hermetet, Camille Denis, Laurianne Hardy, Peggy Suzanne, Romain Douhard, Gaetan Jego, Laurence Dubrez, Oleg N. Demidov, Fabrice Neiers, Loïc Briand, Jana Sopková-de Oliveira Santos, Anne-Sophie Voisin-Chiret, Carmen Garrido. Selecting the first chemical molecule inhibitor of HSP110 for colorectal cancer therapy. Cell Death & Differentiation 2020; 27(1): 117 doi: 10.1038/s41418-019-0343-4
|
6 |
Shaoshan Yang, Xiaoli Ren, Yunshi Liang, Yongrong Yan, Yangshu Zhou, Jinlong Hu, Zhizhi Wang, Fuyao Song, Feifei Wang, Wangjun Liao, Wenting Liao, Yanqing Ding, Li Liang. KNK437 restricts the growth and metastasis of colorectal cancer via targeting DNAJA1/CDC45 axis. Oncogene 2020; 39(2): 249 doi: 10.1038/s41388-019-0978-0
|
7 |
Guillaume Marcion, François Hermetet, Fabrice Neiers, Burhan Uyanik, Lucile Dondaine, Alexandre M. M. Dias, Laurène Da Costa, Mathieu Moreau, Pierre‐Simon Bellaye, Bertrand Collin, Jessica Gobbo, Loïc Briand, Renaud Seigneuric, Olivier Kitten, Mathieu Cinier, Carmen Garrido. Nanofitins targeting heat shock protein 110: An innovative immunotherapeutic modality in cancer. International Journal of Cancer 2021; 148(12): 3019 doi: 10.1002/ijc.33485
|
8 |
Li Xu, Yuan Wang, Xingrui He, Yuan Gao, Frédéric Lirussi, Yi Zhou, Carmen Garrido, Hang Zhang, Tian Xie, Xiang-Yang Ye. Discovery of second generation heat shock protein 110 (HSP110) inhibitors for potential treatment of colorectal cancer. European Journal of Medicinal Chemistry Reports 2023; 7: 100103 doi: 10.1016/j.ejmcr.2023.100103
|
9 |
Junnan Li, Ruizhe Gao, Congke Zhao, Honglin Xiang, Xiangyang Le, Xinyang Zhang, Qinling Cai, Lei He, Qianbin Li, Liqing Hu, Hui Zou. Inhibition of breast cancer growth with AN-329, a novel Hsp110 inhibitor, by inactivating p-STAT3/c-Myc axis. Biomedicine & Pharmacotherapy 2024; 181: 117694 doi: 10.1016/j.biopha.2024.117694
|
10 |
Guangyu Gao, Songtao Liu, Zhen Yao, Yanyan Zhan, Wenyue Chen, Yulong Liu, Ning Cao. The Prognostic Significance of Hsp70 in Patients with Colorectal Cancer Patients: A PRISMA-Compliant Meta-Analysis. BioMed Research International 2021; 2021: 1 doi: 10.1155/2021/5526327
|
11 |
Carlos E. Guerra-Londono, Carlos G. Tarazona, J. A. Sánchez-Monroy, Olivia Heppell, Juan J. Guerra-Londono, Rupen Shah. The Role of Hyperthermia in the Treatment of Peritoneal Surface Malignancies. Current Oncology Reports 2022; 24(7): 875 doi: 10.1007/s11912-022-01275-3
|